Ledger.Open graph →
SEC Form D · filed June 20, 2025

GeneCentric Therapeutics, Inc

Offering
$5.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Prasanth Reddy · Durham, NCDirectorRobert S. Spiegel · Los Altos, CADirectorCharles Perou · Durham, NCDirectorDon Hardison · Boston, MADirectorRamtin R. Agah · Los Altos, CADirectorDon Hardison · Durham, NCDirectorLaurence J. Marton · Los Altos, CADirectorPrasanth Reddy · Durham, NCDirectorUna S. Ryan · Los Altos, CADirectorArnold Levine · Durham, NCDirectorClay Thorp · Durham, NCDirectorChristopher K. Croddy · Brisbane, CADirectorMichael Milburn · Durham, NCExec · DirectorSameer Jafri · Brisbane, CAExec · DirectorShaun R. Bagai · Los Altos, CAExec · DirectorDarshana K. Zaveri · Brisbane, CADirectorMyla Lai-Goldman · Durham, NCDirectorMichael K. Perry · Brisbane, CADirectorRyan K. Drant · Brisbane, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗